Alpha DNA Investment Management’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,982
Closed -$408K 187
2024
Q4
$408K Buy
+23,982
New +$415K 0.16% 168

Other funds holding BTSG

Alpha DNA Investment Management's BTSG Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of BrightSpring Health Services (BTSG) in Q1 2025, closing a stake of 23,982 shares — an estimated $408K sold.

Alpha DNA Investment Management first reported a position in BTSG in Q4 2024 and held it in 1 quarter. The position peaked at $408K in Q4 2024. 163 funds tracked by Wall St. Rank hold BTSG as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining BrightSpring Health Services position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 23,982 BrightSpring Health Services shares in Q1 2025, an estimated $408K.
  • Alpha DNA Investment Management first reported a position in BrightSpring Health Services in Q4 2024 and held it in 1 quarter.
  • Alpha DNA Investment Management's BrightSpring Health Services position peaked at $408K in Q4 2024.
  • 163 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.